Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-0072-2026

LeMaitre Vascular, Inc. recalls Artegraft Collagen Vascular Graft. Model/Catalog/Part Numbers: AG630M

LeMaitre Vascular, Inc.North Brunswick, NJ, United StatesReported Oct 15, 2025 · 9 months ago
Legal News Analyst ·

Reason for recall

Devices were distributed with incorrect label without CE and UKCA mark, missing patient leaflet and patient implant card.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • Artegraft Collagen Vascular Graft. Model/Catalog/Part Numbers: AG630M, AG636M, AG730M, AG740M, AG845M. The Artegraft is intended to serve as a substitute conduit for blood where bypass or replacement of occluded or diseased arterial segments is required or to establish a conduit for hemodialysis
    12 affected lots
    AG630M0031683700001524H361-022AG636M00316837000022AG730M00316837000060AG740M
    +4 more00316837000084AG845M003168370001382027

What the firm is doing

LeMaitre Vascular notified consignees on about 08/25/2025 via letter. Consignees were instructed to identify any affected units in inventory, quarantine those affected units, and arrange for their return. If the product has been implanted, graft explantation/patient intervention is not required. Consignees were also instructed to notify all consignees/customers who should be aware and where affected product has been transferred. Consignees were requested to complete and return the Customer Reply Form. Distributors were requested to indicate that they have quarantine affected units in stock and notified all customers who have received the product.

DistributionShow details

No US distribution. International distribution to Great Britian and Switzerland.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls